Skip to main content
Type at least 3 characters

2,433 articles

Original Research

Published on 13 Dec 2023

Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety

in Neuropharmacology

  • M. T. Corasaniti
  • G. W. Lawrence
  • G. Bagetta
  • R. Iannacchero
  • A. Tarsitano
  • A. Monteleone
  • M. Pagliaro
  • P. Tonin
  • G. Sandrini
  • P. Nicotera
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1296577
  • 4,589 views
  • 2 citations